Detailed Explanation
Study close-out represents the final phase of clinical trial conduct at either the site level when a site completes participation or the study level when the entire trial concludes. This phase ensures orderly completion of all outstanding activities, proper documentation and archival of trial records, appropriate disposition of investigational products and biological samples, and preparation for potential future inspections. Thorough close-out is essential for regulatory compliance and reflects the quality standards maintained throughout the trial.